CIK 0001020214 · Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680262011
- Phone
- 9252886000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy Director bought 1,725 shares at $1.70 ($2,933)
- 4 Open-market sale Director sold 20,000 shares at $1.79 ($35,700)
- 4 Planned sale Chief Legal Officer sold 16,667 shares at $1.71 ($28,501)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Planned sale Chief Financial Officer sold 82,657 shares at an average $2.16 ($178,745)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 16,667 shares at $2.07 ($34,417)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 21,605 shares at $2.50 ($54,013)
Page 7 of 76 · 1,513 filings